Pharmacological studies of 5-methyl-8-ethyl-sulfonyl-10-(2-dimethylaminoethyl)-5H-dibenzo (B,E) (1,4) diazepine-11 (10)-one (SM-307), an antidepressive substance.
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D001463:Barbiturates / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology* / Q000633:toxicity; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D000882:Haplorhini; D007082:Ileum / Q000187:drug effects; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012119:Respiration / Q000187:drug effects
D000928:Antidepressive Agents; D001463:Barbiturates; D003984:Dibenzazepines; D000639:Amitriptyline; D012110:Reserpine; D008995:Monoamine Oxidase; D007099:Imipramine; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine